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Abstract-The addition of lo-’ M to M neomycin to incubations of subcellular fractions of guinea- 
pig cerebral cortex increased the labelling of phosphatidylinositol phosphate and decreased the labelling 
of phosphatidylinositol diphosphate by [y-3ZP]ATP. The effect was observed in all subcellular fractions 
tested and depended on the cationic form of the antibiotic. Similar effects on lipid labelling were 
exerted by related aminoglycosidic antibiotics. by neamine, spermine and poly-L-lysine. Other neomycin 
fragments. antibiotics, local anesthetics or small polyamines were ineffective. Neomycin also inhibited 
the enzymatic hydrolysis of 32P-polyphosphoinositides. The addition of the drug to aqueous dispersions 
of these lipids increased the turbidity and lowered the pH of the suspensions. It is suggested that 
the effects of neomycin on polyphosphoinositide metabolism result from the formation of an ionic 
complex between the lipids and the antibiotic. 
AMINOGLYCOSIDE antibiotics-neomycin, streptomy- 
cin, and related compounds-are potent antibacterial 
agents, but also exert toxic actions on eukaryotic 
cells. These actions include block of neuromuscular 
and ganglionic transmission (PITTINGER & ADAMSON, 
1972), nephrotoxicity, and. most prominently, ototoxi- 
city in the cochlea and the vestibular system (HAW- 
We have recently demonstrated (SCHACHT, 1974; 
ORSULAKOVA et al., 1976) that the incorporation of 
32PI into polyphosphoinositides is altered in inner ear 
tissues of guinea pigs receiving chronic ototoxic doses 
of neomycin. In acute experiments with cochlear per- 
fusions we have shown that the change of polyphos- 
phoinositide labelling followed the same dose re- 
sponse as the decrease of cochlear microphonic 
potential (NUTTALL et a/., 1975). Although a physiolo- 
gical role for the polyphosphoinositides (phosphatidy- 
linositol phosphate and phosphatidylinositol diphos- 
phate) has not yet been established, there are strong 
indications that they are involved in the control of 
membrane permeability in bioelectric events 
(MICHELL, 1975). Of all tissues, brain has the highest 
content of polyphosphoinositides (HAUSER & EICH- 
BERG, 1973) and provides a convenient system to 
study their metabolism. We therefore investigated the 
mechanism of neomycin action o n  the turnover of 
phosphatidylinositol phosphate and phosphatidy- 
linositol diphosphate in subcellular fractions of 
guinea-pig cerebral cortex in uitro. 
KINS, 1970). 
Ahbreviutiom used in tables and figures: PhA. phosphati- 
dic acid (1.2-diacyl-sn-glycero-3-phosphate); PhI. PhIP, 
PhIP,. phosphatidylinositol, phosphate. diphosphate; Nm. 
Neomycin B. 
MATERIALS AND METHODS 
Cerebral cortex from albino guinea-pigs was homo- 
genized in 0.32 M-sucrose in a Teflon-glass homogenizer 
to yield a 10% homogenate (w/v). This was centrifuged 
for 10min at l000g and washed once. The combined 
supernatant fractions were centrifuged for 20 min at 
13,000 g to yield a crude nerve ending-mitochondria1 pellet 
and a supernatant fraction containing cytosol and micro- 
somes. The nerve ending-mitochondria1 pellet was sus- 
pended in 30 ml of 0.32 M-sucrose, and was layered over 
three tubes of a discontinuous gradient consisting of 13 ml 
each of 0.8- and 1.2~-sucrose, which was centrifuged in 
an SW 27 rotor for 120 min at 62,000 g. Fractions collected 
at the interfaces were a myelin-rich fraction over 0.8 M-SUC- 
rose, a nerve ending-rich fraction over 1.2 M-sucrose and 
a pellet containing mitochondria. The fractions were pel- 
leted by centrifuging for 30min at 100,OOOg. Each pellet 
was suspended in 0.16 M-sucrose/S mM-Tris-Cl (pH 7.4) and 
frozen twice in a dry-ice-acetone bath and thawed. 
For lipid labelling, incubations were performed at 37°C 
in air with shaking. The fractions were incubated for 
15 min with 40 mM-Tris-CI (pH 7.4) and 10 m-dithioery- 
thritol, in the presence or absence of drugs; all in a 
volume of 0.25 ml. Then were added (final concentrations) 
80 mM-Tris-Cl (pH 7.4). 20 mM-MgCI,, 0.2 mM-EDTA, and 
4 m~-[y-~’p]ATp; final volume, 0.5 ml. The incubations 
were terminated by the addition of 1.5 ml of chloroform- 
methanol ( I  :2, v/v). After addition of 0.5 ml 2.4 N-HCI and 
1.0 ml of chloroform, mixing and centrifugation, the lower 
phase was collected and the upper phase was reextracted 
with 1.0 ml of chloroform. Samples of the remaining upper 
phase were analyzed for C3’P]ATP (HUANG, 1970). The 
combined lower phases were washed with 2.0ml of meth- 
anolM5 N-HCI (2:3, v/v) and the upper layer was dis- 
carded. Maintainance of high acidity in the upper phase 
during extraction and washing was necessary for complete 
recovery of polyphosphoinositides. Portions of the lower 
phase were removed for the determination of total 
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lipid-"P. the rest was dried under N2. For TLC the lipids 
were taken up in a small volume of chloroform-methanol- 
conc. HCI (6:3:0.1, by vol) and applied to TLC plates 
'Silicagel 60' (E. Merck). Routinely. plates were developed 
in chloroform-methanol--aqueous conc. NH,-H20 
(15:45:3.5: 1 I ,  by vol) which resulted in good separation 
of phosphatidylinositol phosphate. phosphatidylinositol 
diphosphate and phosphatidic acid. "P-lipids were located 
by autoradiography. scraped and counted by liquid scintil- 
lation. Lipid standards for identification were commercial 
(AVANTI. Birmingham. AL) or. in the case of polyphos- 
phoinositides. were prepared according to HENDRICKSOX 
& BALLOU (1964). 
Hydrolysis of phospholipids was studied with previously 
extracted 3'P-labelled lipids. The lipid extract was dried 
under N, and suspended in 40 ~ M - T ~ S - C I  (pH 7.4) with 
a Polytron PT 10-35 (Brinkman 1nstr.I. Portions of this 
suspension were incubated at 37-C with the nerve ending 
fraction in (final concentrations) 80 mM-Tris-CI pH 7.4. 
I mM-NaF, and 1 mM-MgCi,. in a total vol of 0.5 ml. Incu- 
bations were terminated and lipids extracted as above. 
For studies of physicochemical interactions between 
neomycin and the polyphosphoinositides. the lipids were 
prepared by chromatography on DEAE~ellulose (HEY 
DRICKSON & BALLOU, 1964) from bovine brain obtained 
from a local slaughterhouse. The composition of the lipid 
fraction used in these experiments was estimated after TLC 
to be 800/: phosphatidylinositol diphosphate and 20"" 
phosphatidylinositol phosphate with only traces of other 
phospholipids. Dispersions of this lipid fraction in 
20 mM-Tris4 (pH 7.4) were mixed with increasing concen- 
trations of neomycin and turbidity was determined in a 
spectrophotometer at 520 nm (FEINSTEIS. 1964) after a 
stable absorbance was reached. Dilutions of the lipid sus- 
pension with water served as blanks. Neomycin does not 
absorb at 520nm. For pH titrations with neomycin. the 
lipids were suspended in water and the suspension as well 
as the drug were adjusted with HCI or NaOH to 
pH 6.10 & 0.03. Changes of pH of the lipid dispersion 
upon addition of neomxcin were monitored with a pH 
meter. 
[y-"P]ATP was prepared enzymatically (SCHESDEL & 
WELLS, 1973). Lipid phosphorus (AMES & DL'BIN. 1960) and 
protein (LOWRY et a/.. 1951) were determined spectropho- 
tometrically. Neomycin B sulfate and fragments were a gift 
from The Upjohn Co. (Kalamazoo. MI). Radioactive 
materials were purchased from New England Nuclear 
(Boston. MA). 
Data presented are generally averages of at least dupli- 
cate determinations with variability less than 10"". 
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FIG. 1. Time course of 3'P-incorporation into phospho- 
lipids. A nerve ending fraction (0.8 mg protein) was incu- 
bated as described in 'Methods' with 10pCi 32P-ATP. 
phosphatidic acid: 0-0 phosphatidylinositol 
phosphate: A-A phosphatidylinositol diphosphate. 
Open symbols: controls; closed symbols: M- 
neomycin. 
RESULTS 
Lahellirig qf' subcellular fractions 
Fractions obtained by differential and density gra- 
dient centrifugation were incubated with [y-32P]ATP 
in the absence or presence of M-neomycin (Table 
1). Phosphatidic acid, phosphatidylinositol phosphate 
and phosphatidylinositol diphosphate were the only 
significantly labelled lipids, as confirmed by two 
dimensional TLC (EICHBERG et d., 1973). The nerve 
ending fraction showed the highest activity of incor- 
poration per mg protein. The  addition of neomycin 
increased phosphatidylinositol phosphate labelling in 
all fractions 1.5- to 2-fold, whereas phosphatidy- 
linositol diphosphate labelling was generally de- 
creased. Radioactivity in phosphatidic acid did not 
seem to  be affected with the possible exception of 
the myelin-rich fraction. 
The  time course of labelling (Fig. 1) showed linear- 
ity of 3'P-incorporation for somewhat less than 5 min. 
The effect of I O w 4  M-neomycin on polyphosphoinosit- 
ide labelling was evident at all times, while n o  in- 
fluence was observed on phosphatidic acid labelling. 
Eflect of rwoniycin 
The  changes of '*P-incorporation into the poly- 
phosphoinositides depend o n  the concentration of 
TABLE I .  LABELLING OF PHOSPHOLIPIDS I N  SL~BCELLULAR FRACTIONS 
mg protein PhIP PhIPz PhA 




13.0oO g supernatant 
d.p.m. incorporated 
0.7 782 1364 186 247 322 385 
0.4 2900 4677 1160 596 695 588 
0.2 811 1210 322 233 352 192 
1 .0 2490 3740 1530 1375 3178 3175 
The fractions were incubated with IOpCi ':P-ATP for 5 min as described in 'Methods'. Neomycin 
was ~ O - ' M .  
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FIG. 2. Effect of neomycin concentration on labelling of 
polyphosphoinositides. A nerve ending fraction (0.6 mg 
protein) was incubated as described in ‘Methods’ with 
I2pCi 32P-ATP for 5min. 
neomycin (Fig. 2). Both the decrease in 32P-phospha- 
tidylinositol diphosphate and the increase in 
32P-phosphatidylinositol phosphate are clearly evi- 
dent at 10-4~-neomycin and in some cases-as in 
the experiment presented-small effects could be 
observed at  M drug. 
The incubation medium was similar to that of KAI 
et ul. (1968) and had been modified to promote the 
highest rate of 32P-incorporation into the polyphos- 
phoinositides. Variation of its composition did not 
significantly influence the effect of neomycin except 
when changes in the magnesium concentration (Table 
2) or in pH (Fig. 3) were made. With increasing 
Mg2+,  the basal rate of labelling of phosphatidy- 
linositol phosphate was enhanced about six-fold while 
the relative effect of neomycin (percentage stimu- 
lation) was decreased. Phosphatidylinositol diphos- 
phate also responded to Mgz+,  and neomycin which 
inhibited its labelling at higher Mg2+ slightly stimu- 
lated it at 1 mM-MgC1,. 
A rather broad pH optimum is observed for the 
32P-incorporation into phosphatidylinositol phos- 
TABLE 2. EFFECT OF MgCI2 ON NEOMYCIN STIMULATED 
POLYPHOSPHOINOSITIDE LABELLING 
PhIP PhIP, 
MgCl2 Control +Nm Control +Nm 
d.p.m. incorporated 
1 mM 136 22.50 745 930 
5 mM 1787 3895 1932 16.55 
20 mM 4470 6520 2180 1560 
A nerve ending fraction (?mg protein) was incubated 
as described in ‘Methods’ with MgC1, as indicated and 
18 pCi 32P-ATP for 5 min. Neomycin was 2 x M. 
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FIG. 3. Effect of pH on neomycin stimulation 01 phosphati- 
dylinositol phosphate labelling. A nerve ending fraction 
(2 mg protein) was incubated with 7 ItCi 32P-ATP for 5 min 
as described in ‘Methods’ except that MgCI, was SmM 
and Tris maleate was substituted for Tris-CI. Open sym- 
bols: controls: closed symbols: 10~4M-neomycin. 
phate (and for diphosphate, not shown). At pH8.5 
labelling proceeds at about 8004 and at p H 9  at SO:/, 
of the maximal rate. In contrast, stimulation by neo- 
mycin is essentially abolished at pH 8.5 and 9.0. 
Compurison with other drugs 
The action of neomycin was compared with that 
of a number of other drugs (Table 3). 
Tobramycin, gentamicin and kanamycin. which are 
desoxystreptamine antibiotics, as is neomycin. stimu- 
lated labelling of phosphatidylinositol phosphate. 
Streptomycin an aminoglycoside of the streptidine 
group decreased 3’P-phosphatidylinositol diphos- 
phate (Table 3, Exp. A). Of the neomycin fragments 
(Exp. B) only neamine was found to increase phos- 
phatidylinositol labelling. The magnitude was less 
than with the intact antibiotic, but a stimulation was 
consistently observed in a number of experiments. 
Other inhibitors of bacterial protein synthesis, such 
as puromycin and clindamycin or local anaesthetics 
(Exp. C) were ineffective. The polyamine spermine, 
however, and the polyamino acid poly-L-lysine (Exp. 
D) altered polyphosphoinositide labelling similarly to 
neomycin. 
In most of these experiments, [y-32P]ATP was 
measured at  the end of the incubation time. About 
307, of the intially added ATP was usually recovered, 
and M-neomycin decreased this amount by 
about 10% (i.e. 25-27”/, recovered). The increased hy- 
drolysis of ATP in the presence of neomycin may 
account for some of the drug effect on phosphatidic 
acid labelling. A consistent decrease of [ 32P]phospha- 
tidate could only be observed at higher drug concen- 
trations. In contrast to neomycin, poly-L-lysine inhi- 
bited the hydrolysis of ATP slightly (about 15%). 
Other drugs did not show effects that exceeded loo/;. 
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TABLE 3. EFFECT OF VARIOUS DRUGS OS THE LABELLISG OF 
PHOSPHOLIPIDS 
Drug ( 1 0 - ' ~ )  PhIP PhIPz PhA 










Exp. B None 
biosaminid 
streptamine 
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Incubations were performed as described in 'Methods' 
Exp. A :  1.1 mg protein of nerve ending fraction. I4pCi 
Exp. B and C: 1.3 mg protein of nerve ending fraction. 
8pCi 3ZP-ATP. - , 
Exp. D: 1.3 mg protein of nerve ending fraction. 12 pCi 
32P-ATP. 
Poly-L-lysine. average MW 3400. Molarity in table is 
given as molarity with respect to lysine residues for com- 
parison with the monomers. * I  mM' corresponds to 
0.04 mwpolymer. 
with 5 mM-MgC1,. 
"P-ATP. 
Hydrolysis of polr:phosphoiiiositides 
For the study of the enzymatic hydrolysis of poly- 
phosphoinositides, lipids were labelled by 
[Y-~'P]ATP as described above. extracted and added 
to assays with the nerve ending fraction. Only little 
hydrolysis was observed when the conditions of the 
labelling studies (ATP omitted) were employed. In a 
medium more suitable for the assay of polyphos- 
phoinositide phosphomonoesterases and phospho- 
diesterases (SHELTAWY et al.. 1972; KEOLGH & 
THOMPSON, 1972), the rate of hydrolysis was almost 
linear for 20min during which about 30"', of both 
lipids were hydrolysed (Fig. 4). There was n o  non- 
enzymatic breakdown under these conditions. Neo- 
mycin was inhibitory a t  concentrations of lo-' M or  
higher (Fig. 5). 
In these experiments where n known amount of 
32P-polyphosphoinositides was added to the incuba- 
tion medium,.no influence of neomycin on the recov- 
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FIG. 4. Time course of hydrolysis of polyphosphoinosit- 
ides. A nerve ending fraction (1.1 mg protein) was incu- 
bated with previously labelled lipids as described in 
'Methods'. Closed symbol: incubation with bovine serum 
albumin substituting for nerve ending fraction. 
Drugllipid iiiteractioiis 
Low concentrations of neomycin increased the tur- 
bidity of buffered aqueous dispersions of polyphos- 
phoinositides (Fig. 6). At a lipid concentration of 
600 
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FIG. 5. Effect of neomycin concentration on hydrolysis of 
polyphosphoinositides. A nerve ending fraction (1.1 mg 
protein) was incubated with previously labelled lipids for 
20min as described in 'Methods'. O-* PhIP, A-A 
PhIP,; Symbols at the left ordinate: control incubation 
without drug. Half closed symbols at the right ordinate: 
"P-lipid present at the start of the incubation: fully closed 
symbols: same. but extraction in the presence of 
ery could be detected (Fig. 5). I 0- ' M-neomycin 
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0.4 mM-lipid-phosphate, 40 pM-neomycin produced 
maximal turbidity. The same concentration of the 
drug decreased the pH of an unbuffered aqueous 
polyphosphoinositide suspension (0.2 m-lipid-phos- 
phate) from 6.1 to 5.6 indicating an ionic exchange 
between the hydrogen of the lipid phosphate and neo- 
mycin. 
DISCUSSION 
The rapid hbekng of phosphatidylinositol phos- 
phate and phosphatidylinositol diphosphate in brain 
subcellular fractions in uitro by the reactions (COLOD- 
ZIN & KENNEDY, 1965; KAI et al., 1968): 
Phosphatidylinositol + [ Y - ~ ~ P I A T P  -+ 
phosphatidylinositol [32P]phosphate + ADP (I) 
Phosphatidylinositol phosphate + [Y-~’P]ATP --+ 
phosphatidylinositol [32P]diphosphate + ADP (11) 
makes this an easily accessible system for the study 
of polyphosphoinositide metabolism. In this study we 
see a pronounced stimulation of 32P-incorporation 
into phosphatidylinositol phosphate and a decrease 
of incorporation into phosphatidylinositol diphos- 
phate in the presence of neomycin. Labelling of phos- 
phatidate, the only other highly labelled lipid, 
remained largely unaffected at low drug concen- 
trations. 
The susceptibility to neomycin did not seem to be 
associated with a particular subcellular fraction. The 
nerve ending fraction was selected for further studies 
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FIG. 6. Effect of neomycin on the turbidity of an aqueous 
dispersion of polyphosphoinositides. Neomycin (aliquots of 
a 0.5 mM solution) was added to a dispersion of polyphos- 
phoinositides in 20 mM-Tris CI pH 7.4, (0.4 mM lipid phos- 
phate) as described in ‘Methods’. Turbidity was measured 
at 520nm, volume I ml. 
the lipids. The requirement for high magnesium con- 
centrations for phosphatidylinositol and phosphatidy- 
linositol phosphate kinase reactions is known (KAI 
et al., 1966, 1968), and was confirmed in our exper- 
iments. Low concentrations of Mg2 + appeared to 
favor a higher (percentage) stimulation of phosphati- 
dylinositol phosphate labelling by neomycin. but the 
stimulatory effect on the diphosphate was inconsistent 
in a number of experiments. Five mM-Mg2+ pro- 
moted almost maximal labelling of phosphatidy- 
linositol diphosphate and a pronounced and repro- 
ducible effect of the drug on both polyphosphoinosit- 
ides. Variation of the pH of the incubation medium 
significantly changed the antibiotic action. With in- 
creasing pH, basal labelling of phosphatidylinositol 
phosphate is only slightly affected while the stimu- 
lation by neomycin is reduced. At pH 9, no drug effect 
is evident. Since the apparent pK of neomycin is 
approx. 8.2 (KOEPSELL & FORD, 1958) this indicates 
that the cationic form of the antibiotic is the active 
species in changing the lipid labelling. 
It appears unusual that labelling of phosphatidy- 
linositol phosphate and diphosphate are affected in 
opposite ‘ways. A number of previous studies have 
indicated that both lipids show a similar response to 
drugs or experimental conditions that change their 
turnover (WHITE et al.. 1974; SCHACHT & AGFUNOFF, 
1972a, b;  LLOYD et al., 1972). Since phosphatidyl- 
inositol kinase and phosphatidylinositol phosphate 
kinase are distinct enzymes, a differential action by 
neomycin is not surprising. Inhibition of the latter 
enzyme might explain all of the observed effects on 
32P-incorporation. A stimulation of phosphatidy- 
linositol diphosphate phosphomonesterase might also 
be considered to explain the incorporation studies, 
but this mechanism is contradicted by the inhibition 
of polyphosphoinositide breakdown evident in exper- 
iments in which neomycin was added to previously 
labelled lipids. Examination of the action of a number 
of other drugs suggests. however, a third mechanism. 
The neomycin effect is class-specific. It is shared by 
structurally-related antibiotics of the aminoglycoside 
group, but not by other antibacterial agents or local 
anesthetics. The latter are also known to interact with 
phospholipids. EICHBERG & HAUSER (1 974) reported 
a stimulation by cocaine and lidocaine of 32Pi incor- 
poration into acidic phospholipids in the intact pineal 
gland. FEINSTEIN (1964) described the formation of 
ionic complexes between local anaesthetics and phos- 
pholipids. In this study, only polyamines produce 
changes in lipid labelling like those produced by neo- 
mycin. Poly-L-lysine has been reported to form in- 
soluble mixed complexes with Me (11) ions and phos- 
phatidylinositol diphosphate (FULLINGTON & HEN- 
DRICKSON, 1966) and we suggest a similar action for 
neomycin. The turbidity experiment confirms the for- 
mation of a complex between polyphosphoinositides 
and the drug. The displacement of H +  from the poly- 
phosphoinositides indicates that the complex is based 
on ionic interactions, which is supported by the fact 
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that the neomycin cation is required for the effect 
on lipid labelling. 
Our study then suggests that the binding of neo- 
mycin to the polyphosphoinositides renders these 
lipids unavailable as substrates for the phosphoester- 
ases and for phosphatidylinositol kinase. This 
assumption of a complex formation between neo- 
mycin and the polyphosphoinositides is sufficient to 
explain the observed it7 iiitro effects as well as the 
in viuo neomycin action on inner ear tissues as we 
have previously speculated (ORSULAKOVA et a/.. 1976). 
Cellular toxicity of polycations including poly-~-  
lysine is documented for the rat kidney (SEILER, et 
al., 1975). Ototoxic effects of polycations have, to our 
knowledge. not been reported. Preliminary studies 
(Nuttall & Schacht, unpublished) indicate that sper- 
mine as well as poly-L-lysine decrease the cochlear 
microphonic potential when administered by cochlear 
perfusion. Thus, the ototoxicity of neomycin may well 
be due to the polyamine character of the drug. 
It should be expected that neomycin will also bind 
to other acidic phospholipids. This question still has 
to be examined. but this study indicates some prefer- 
ential action on polyphosphoinositides at low drug 
concentrations. Moreover, our in Liuo studies of neo- 
mycin toxicity in the inner ear (ORSULAKOVA et a/., 
1976) and recently in the kidney (SCHIBECI & 
SCHACHT, 1976) demonstrated a neomycin effect on 
the polyphosphoinositides but not on other lipids. 
Further investigations of drugilipid interactions in 
artificial membranes (LODHI et a/., 1976) should help 
to elucidate this point. Knowledge of the specificity 
of the neomycin action and of its physiological effects 
in uivo may contribute to our understanding of the 
functional significance of the polyphosphoinositides. 
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